← Eichor
Condition: Idiopathic Membranous Nephropathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Idiopathic Membranous Nephropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Phase 3 · 31 location(s) · Cerium Pharmaceuticals, Inc. · NCT05696613Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharm
Phase 2 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07289763An Outcome Analysis of Primary Membranous Nephropathy
Phase N/A · 2 location(s) · Mario Negri Institute for Pharmacological Research · NCT06242327NEPTUNE Match Study
NA · 16 location(s) · University of Michigan · NCT04571658A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Phase 1/Phase 2 · 19 location(s) · Nkarta, Inc. · NCT06557265A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Sev
Phase 2 · 1 location(s) · SynAct Pharma Aps · NCT04456816Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Phase N/A · 1 location(s) · University of Michigan · NCT05505500A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Phase 2/Phase 3 · 21 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT06470191OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
Phase 3 · 1 location(s) · Huashan Hospital · NCT06781944A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With
Phase 2 · 17 location(s) · Shanghai Henlius Biotech · NCT07038382A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Phase 2 · 43 location(s) · Climb Bio, Inc. · NCT07096843Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome
Phase 3 · 18 location(s) · Shoichi Maruyama MD PhD · NCT05914155Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT04326218Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · 108 location(s) · Vertex Pharmaceuticals Incorporated · NCT07204275Raman Spectroscopy Diagnosis of Kidney Diseases
Phase N/A · 1 location(s) · Zunsong Wang · NCT06760845A Real World Study About PMN
Phase N/A · 1 location(s) · Wei Chen · NCT06893328Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropat
Phase 1 · 1 location(s) · The First Affiliated Hospital of Air Force Medicial Universi · NCT07266181Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Phase 1 · 19 location(s) · Everest Medicines (China) Co.,Ltd. · NCT05800873Nephrotic Syndrome Study Network
Phase N/A · 44 location(s) · University of Michigan · NCT01209000Atacicept in Multiple Glomerular Diseases
Phase 2 · 1 location(s) · Vera Therapeutics, Inc. · NCT06983028China Kidney Patient Trials Network
Phase N/A · 1 location(s) · George (Beijing) Clinical Research Co. Ltd. · NCT05036850Study of YK012 in Primary Membranous Nephropathy
Phase 1 · 1 location(s) · Excyte Biopharma Ltd · NCT06982729Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Phase 2 · 2 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00977977Different Immunosuppressive Treatment in iMN
Phase 3 · 1 location(s) · Peking Union Medical College Hospital · NCT04745728SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NA · 14 location(s) · Meyer Children's Hospital IRCCS · NCT07516964A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous
Phase 1 · 6 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT05668403A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · 22 location(s) · AstraZeneca · NCT07571746National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
Phase 2/Phase 3 · 1 location(s) · Radboud University Medical Center · NCT07163611
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.